Teladoc Health (NYSE:TDOC) Releases Q2 Earnings Guidance

Teladoc Health (NYSE:TDOC) issued an update on its second quarter earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of ($0.45)-($0.35) for the period, compared to the consensus estimate of ($0.30). The company issued revenue guidance of $635-$660 million, compared to the consensus revenue estimate of $662.55 million. Teladoc Health also updated its FY24 guidance to ($1.10)-($0.80) EPS.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Piper Sandler lowered their target price on shares of Teladoc Health from $30.00 to $25.00 and set an overweight rating on the stock in a research note on Wednesday, February 21st. DA Davidson lowered their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a neutral rating on the stock in a research note on Wednesday, February 21st. Royal Bank of Canada decreased their target price on shares of Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a research note on Friday. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $28.00 to $25.00 and set a buy rating for the company in a report on Friday. Finally, TD Cowen cut their target price on shares of Teladoc Health from $16.00 to $15.00 and set a hold rating for the company in a report on Friday. Eleven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of Hold and an average price target of $19.67.

Teladoc Health Trading Down 2.4 %

Shares of TDOC traded down $0.32 during mid-day trading on Friday, hitting $13.01. 7,696,741 shares of the company traded hands, compared to its average volume of 4,813,149. Teladoc Health has a 1-year low of $12.65 and a 1-year high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The business has a 50 day moving average of $15.01 and a 200 day moving average of $17.77.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.11%. The company had revenue of $646.13 million for the quarter, compared to analyst estimates of $637.31 million. During the same quarter last year, the company earned ($0.37) EPS. The business’s revenue was up 2.7% compared to the same quarter last year. Equities analysts predict that Teladoc Health will post -1.07 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction that occurred on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total value of $151,176.76. Following the transaction, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The sale was disclosed in a filing with the SEC, which is available through this link. In other Teladoc Health news, CAO Richard J. Napolitano sold 3,765 shares of the company’s stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $54,667.80. Following the sale, the chief accounting officer now owns 18,077 shares in the company, valued at approximately $262,478.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Laizer Kornwasser sold 7,882 shares of the company’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $19.18, for a total value of $151,176.76. Following the completion of the sale, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,441 shares of company stock worth $2,038,251. 1.63% of the stock is owned by company insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.